- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2162-3619
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH) ; volume:8 ; number:1 ; day:21 ; month:8 ; year:2019 ; pages:1-7 ; date:12.2019
Experimental hematology & oncology ; 8, Heft 1 (21.8.2019), 1-7, 12.2019
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Lobry, Camille
Bains, Ashish
Zamechek, Leah B.
Ibrahim, Sherif
Aifantis, Iannis
Araten, David J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40164-019-0142-0
- URN
-
urn:nbn:de:101:1-2020010319514994123748
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lobry, Camille
- Bains, Ashish
- Zamechek, Leah B.
- Ibrahim, Sherif
- Aifantis, Iannis
- Araten, David J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Paroxysmal nocturnal hemoglobinuria: Where we stand
The complement model disease paroxysmal nocturnal hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
Molecular analysis of the GPI-deficient clonal hematopoiesis in paroxysmal nocturnal hemoglobinuria
Molecular analysis of the GPI-deficient clonal hematopoiesis in paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria and related disorders : molecular aspects of pathogenesis
Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
Paroxysmal nocturnal hemoglobinuria in systemic lupus erythematosus: a case report
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
The Antibody Repertoire of Patients with Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome
Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal nocturnal hemoglobinuria: Where we stand
The complement model disease paroxysmal nocturnal hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
Molecular analysis of the GPI-deficient clonal hematopoiesis in paroxysmal nocturnal hemoglobinuria
Molecular analysis of the GPI-deficient clonal hematopoiesis in paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria and related disorders : molecular aspects of pathogenesis
Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
Paroxysmal nocturnal hemoglobinuria in systemic lupus erythematosus: a case report
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
The Antibody Repertoire of Patients with Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome
Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients
A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal nocturnal hemoglobinuria: Where we stand
The complement model disease paroxysmal nocturnal hemoglobinuria
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment
Molecular analysis of the GPI-deficient clonal hematopoiesis in paroxysmal nocturnal hemoglobinuria
Molecular analysis of the GPI-deficient clonal hematopoiesis in paroxysmal nocturnal hemoglobinuria
Paroxysmal nocturnal hemoglobinuria and related disorders : molecular aspects of pathogenesis
Correction to: Pegcetacoplan: A Review in Paroxysmal Nocturnal Haemoglobinuria
Paroxysmal nocturnal hemoglobinuria in systemic lupus erythematosus: a case report
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria
The Antibody Repertoire of Patients with Paroxysmal Nocturnal Hemoglobinuria and Myelodysplastic Syndrome
Eculizumab for paroxysmal nocturnal haemoglobinuria: catastrophic health expenditure in Nepalese patients